We serve Benzyl Glycidyl Ether CAS: 89616-40-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Test Items | Condition | Result |
| MFG.DATE | ——- | 20180901 |
| Appearance | Colorless transparent | Colorless transparent liquid |
| Color, APHA | ≤50 | 5 |
| Viscosity ， mPas (25℃) |
4～10 | 5 |
| Epoxy value，eq/100g | 0.44-0.49 | 0.461 |
| Hydrolyzable chloride，eq/100g | ≤0.02 | 0.0031 |
| Inorganic chlorine， eq/100g | ≤0.005 | 0.0025 |
| Moisture content, % | ≤0.1 | 0.0063 |
Contact us for information like Benzyl Glycidyl Ether chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,OXIRANE,2-[(PHENYLMETHOXY)METHYL]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzyl Glycidyl Ether Use and application,BENZYL GLYCIDYL ETHER technical grade,usp/ep/jp grade.
Related News: “We will continue to closely monitor the situation and we look forward to reopening our stores as soon as possible.”3-Pyridinecarboxylic acid, 2-amino-5-cyano-6-(methylthio)-, ethyl ester manufacturer Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.4-benzyloxy-2-[(di-N,N-methylamino)methylene]amino-6-[2-(N,N-dimethylamino)vinyl]-5-nitropyrimidine supplier Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.2,3,4,6-tetra-O-acetyl-D-glucono-1,5-lactone vendor Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.
